Multicenter Study to Assess the Efficacy of Decitabine in the Treatment of Chronic Myelomonocytic Leukemia

NCT01251627 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

43

Enrollment

OTHER

Sponsor class

Conditions

Chronic Myelomonocytic Leukemia

Interventions

DRUG: Decitabine

Sponsor

Fondazione Italiana Sindromi Mielodisplastiche-ETS

Collaborators

[object Object]